Patient-Reported Outcomes Reinforce Efficacy of Natalizumab for MS
Researchers gathered data on patient-reported outcomes to support evidence for the continuation of natalizumab, a disease-modifying treatment, in the management of multiple sclerosis (MS) progression.
New York United States York State Ms Consortium Questionnaire Concept Expanded Disability Status Scale New York State
Source: ajmc.com